Summary
Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF is an ETF - a fund traded on an exchange like a stock - run by Corgi Funds. Positions inside: 59. The ten largest make up 49% of the fund.
- Yearly costs
- 0.35%
- Fund size
- $1.25M
- Positions
- 59
- Running since
- 2026
What speaks for it
- Costs of 0.35% a year are below the middle of comparable funds (0.44%).
What to watch
- 95% of the fund is in one sector (Healthcare).
- 92% of the fund is in one country (United States).
- A young fund: it has been running only since 2026.
- A small fund with $1.25M under management; small funds get closed more often.
- It trades little: only about $60.1K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -0.3%
- 3 months
- +22%
- Avg. market cap
- $51.3B
- P/E
- -
- Forward P/E
- -
- P/S
- 6.2x
- P/B
- 4.3x
- P/FCF
- -
- EV/EBITDA
- 19.4x
- Dividend yield
- 0.05%
- ROIC
- -10.3%
- ROE
- -15.6%
- Gross margin
- 17.2%
- Operating margin
- -259.2%
- Net margin
- -236.9%
- Payout ratio
- -
- Net debt/EBITDA
- -0.3x
- Beta
- 2.27
Weighted average of the 50 largest companies, which make up 95% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Moderately concentrated- 1 MRModerna MRNA 10%
- 2 TMThermo Fisher Scientific TMO 9.3%
- 3 VRVertex Pharmaceuticals VRTX 5.9%
- 4 ILIllumina ILMN 4.9%
- 5 GHGuardant Health GH 3.5%
- 6 TX10x Genomics, Inc. TXG 3.2%
- 7 GMGenmab A/S GMAB 3.2%
- 8 IOIovance Biotherapeutics, Inc. IOVA 3.1%
- 9 RVRevolution Medicines RVMD 3.1%
- 10 INIncyte INCY 2.7%
Positions in the fund: 59. The ten largest make up 49% of it.
Composition as of Oct 18, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 95%
- Technology 2.0%
- Other 2.6%
By country
- United States 92%
- Denmark 3.1%
- Netherlands 2.8%
- Switzerland 1.9%
By company size
- Mega cap 9.7%
- Large cap 43%
- Mid cap 31%
- Small cap 14%
- Micro cap 1.6%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (95%). Largest country: United States (92%). Largest size group: Large cap (43%).
What does it cost me?
Cheap- A year from $10,000
- $35.00
- Over 20 years
- $1,714
From every $10,000 invested the fund takes $35.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $1,714.
How has it done?
- Deepest drop
- -9.0%
- Yearly volatility
- 510%
It has traded for less than a year, too short to judge.
Does it pay dividends?
We have no record of payments from this fund.
Is it easy to buy and sell?
It trades little- Traded a day
- $60.1K
- Shares a day
- 1.7K
On an average day about $60.1K of the fund changes hands.
How expensive are the companies inside?
Rather expensive- Average Bulios Score
- 45 out of 100
Weight by Bulios Fair Price
- Undervalued 14%
- Fairly valued 0.0%
- Overvalued 86%
By Fair Price, 86% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 95% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
GN GNOM Global X - Genomics & Biotechnology ETF | United States | 0.50% | $103.2M | +47% | Pays out | 48% |
WD WDNA WisdomTree BioRevolution Fund | United States | 0.45% | $2.89M | +26% | Pays out | 37% |
HL HLTH Tema Healthcare AI ETF | United States | 0.75% | $1.08M | - | - | 34% |
AR ARKG ARK Genomic Revolution ETF | United States | 0.75% | $1.63B | +41% | Reinvests | 32% |
IB IBB iShares Biotechnology ETF | United States | 0.44% | $10.5B | +30% | Pays out | 32% |
BB BBH VanEck Biotech ETF | United States | 0.35% | $486.7M | +35% | Pays out | 32% |
